X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (90) 90
Book / eBook (8) 8
Conference Proceeding (8) 8
Newspaper Article (8) 8
Publication (7) 7
Book Chapter (2) 2
Dissertation (2) 2
Magazine Article (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (35) 35
humans (30) 30
aged (18) 18
male (18) 18
female (17) 17
adult (15) 15
middle aged (15) 15
research (11) 11
oncology (10) 10
studies (10) 10
united states (10) 10
cost-benefit analysis (9) 9
retrospective studies (9) 9
analysis (8) 8
child, preschool (8) 8
abridged index medicus (7) 7
adolescent (7) 7
disease (7) 7
infant (7) 7
prevention (7) 7
usage (7) 7
vaccines (7) 7
animals (6) 6
children (6) 6
cohort studies (6) 6
health care sciences & services (6) 6
history (6) 6
immunization (6) 6
infectious diseases (6) 6
mice (6) 6
models, economic (6) 6
research article (6) 6
united states - epidemiology (6) 6
young adult (6) 6
child (5) 5
health aspects (5) 5
health policy & services (5) 5
immunology (5) 5
incidence (5) 5
medicine, research & experimental (5) 5
mortality (5) 5
pneumococcal infections - prevention & control (5) 5
population (5) 5
treatment outcome (5) 5
vaccination (5) 5
age (4) 4
cancer (4) 4
care and treatment (4) 4
chronic myelogenous leukemia (4) 4
cost analysis (4) 4
cost-effectiveness (4) 4
costs (4) 4
databases (4) 4
impact (4) 4
influenza (4) 4
medicine, general & internal (4) 4
morbidity (4) 4
pneumococcal infections - epidemiology (4) 4
pneumococcal vaccine (4) 4
pneumonia (4) 4
therapy (4) 4
time factors (4) 4
united-states (4) 4
acute disease (3) 3
adolescents (3) 3
adults (3) 3
aged, 80 and over (3) 3
asthma (3) 3
chronic myeloid leukemia (3) 3
comorbidity (3) 3
computer science, information systems (3) 3
costs and cost analysis (3) 3
dasatinib (3) 3
databases, factual (3) 3
diphtheria-tetanus-pertussis vaccine - economics (3) 3
disease control (3) 3
double-blind method (3) 3
economic aspects (3) 3
economics (3) 3
genetic aspects (3) 3
health administration (3) 3
health services research (3) 3
hematology (3) 3
heptavalent pneumococcal conjugate vaccine (3) 3
hospitalization - economics (3) 3
imatinib (3) 3
infant, newborn (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
libraries (3) 3
markov chains (3) 3
mice, inbred c57bl (3) 3
multidisciplinary sciences (3) 3
pharmacology & pharmacy (3) 3
pneumococcal vaccines - administration & dosage (3) 3
pneumococcal vaccines - economics (3) 3
protein kinase inhibitors - therapeutic use (3) 3
public health (3) 3
social aspects (3) 3
streptococcus infections (3) 3
vaccination - economics (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Faculty of Information - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 15, pp. 2875 - 2880
In patients who have chronic‐phase chronic myeloid leukemia (CML) with the Philadelphia chromosome threonine to isoleucine mutation at codon 315, single‐agent... 
threonine to isoleucine mutation at codon 315 (T315I) | Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ ALL) | ponatinib | allogeneic stem cell transplantation (allo‐SCT) | chronic myeloid leukemia (CML) | Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) | allogeneic stem cell transplantation (allo-SCT) | RESISTANT | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | MARGINAL STRUCTURAL MODELS | PHASE-2 | INHIBITORS | Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) | CHRONIC MYELOID-LEUKEMIA | Multivariate Analysis | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - therapeutic use | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Transplantation, Homologous | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Adult | Female | Retrospective Studies | Imidazoles - therapeutic use | Philadelphia Chromosome | Pyridazines - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Blast Crisis - therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Stem Cell Transplantation - methods | Aged | Blast Crisis - genetics | Mutation | Chemotherapy | Usage | Care and treatment | Gene mutations | Stem cells | Transplantation | Chronic myeloid leukemia | Diagnosis | Research | Cancer | Intervention | Transplants & implants | Leukemia | Bone marrow transplantation | Stem cell transplantation | Blast | Confidence intervals | Bone marrow | Chromosomes | Age | Isoleucine | Cell survival | Acute lymphatic leukemia | Threonine | Myeloid leukemia | Hazards | Crises | Lymphatic leukemia | Patients | Survival | Philadelphia chromosome | Index Medicus | Abridged Index Medicus | Original
Journal Article
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 03/2019, Volume 35, Issue 3, pp. 479 - 487
Objective: Comparing the benefit-risk profiles of ponatinib vs. bosutinib in third-line (3L) treatment of chronic phase chronic myeloid leukemia (CP-CML) is... 
chronic myeloid leukemia | chronic myelogenous leukemia | ponatinib | tyrosine kinase inhibitor | Indirect comparison | bosutinib | MEDICINE, RESEARCH & EXPERIMENTAL | COMPARATIVE EFFICACY | DASATINIB | NILOTINIB | ABL INHIBITOR | MEDICINE, GENERAL & INTERNAL | IMPACT | THERAPY | IMATINIB | SKI-606 | MUTATIONS
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, pp. e67260 - e67260
Journal Article
Journal Article
PLoS ONE, 09/2013, Volume 8, Issue 9
Objectives Health benefits and costs of combined reduced-antigen-content tetanus, diphtheria, and pertussis (Tdap) immunization among adults greater than or... 
Advisory committees
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 05/2013, Volume 13, Issue 1, pp. 229 - 229
Journal Article
The American journal of managed care, ISSN 1088-0224, 07/2010, Volume 16, Issue 7, pp. e174 - 187
Journal Article